Evolent Announces New CFO and Inducement Award Under NYSE Listing Rule

Evolent Health, a company specializing in better health outcomes for people with complex conditions, announced a one-time restricted stock unit award to its new Chief Financial Officer, Mario Ramos. The award covers 587,500 shares of Evolent Class A common stock and has a grant date value of $2.35 million. It vests 34% on the first anniversary of the grant date, 33% on the second anniversary, and 33% on the third anniversary, contingent on Ramos' continued employment.